|
Originally published In Press as doi:10.1074/jbc.M100659200 on April 9, 2001
J. Biol. Chem., Vol. 276, Issue 26, 24186-24193, June 29, 2001
Structure of a Pilin Monomer from
Pseudomonas aeruginosa
IMPLICATIONS FOR THE ASSEMBLY OF PILI*
David W.
Keizer ,
Carolyn M.
Slupsky ,
Michal
Kalisiak §,
A.
Patricia
Campbell¶,
Matthew P.
Crump ,
Parimi A.
Sastry§,
Bart
Hazes§,
Randall T.
Irvin §, and
Brian D.
Sykes **
From the Protein Engineering Network Centres of
Excellence (PENCE), 713 Heritage Medical Research Centre, University of
Alberta, Edmonton, Alberta T6G 2S2, Canada, the § Department
of Medical Microbiology and Immunology, University of Alberta,
Edmonton, Alberta T6G 2H7, Canada, the Department of
Biochemistry, University of Southampton, Bassett Crescent East,
Southampton SO16 7PX, United Kingdom, and the ¶ Department of
Medicinal Chemistry, School of Pharmacy, University of Washington,
Seattle, Washington 98195
Received for publication, January 24, 2001, and in revised form, March 13, 2001
 |
ABSTRACT |
Type IV pilin monomers assemble to form fibers
called pili that are required for a variety of bacterial functions.
Pilin monomers oligomerize due to the interaction of part of their
hydrophobic N-terminal -helix. Engineering of a truncated pilin from
Pseudomonas aeruginosa strain K122-4, where the first 28 residues are removed from the N terminus, yields a soluble, monomeric
protein. This truncated pilin is shown to bind to its receptor and to
decrease morbidity and mortality in mice upon administration 15 min
before challenge with a heterologous strain of Pseudomonas.
The structure of this truncated pilin reveals an -helix at the N
terminus that lies across a 4-stranded antiparallel -sheet. A model
for a pilus is proposed that takes into account both electrostatic and
hydrophobic interactions of pilin subunits as well as previously
published x-ray fiber diffraction data. Our model indicates that DNA or RNA cannot pass through the center of the pilus, however, the possibility exists for small organic molecules to pass through indicating a potential mechanism for signal transduction.
 |
INTRODUCTION |
Pseudomonas aeruginosa is a common, rod-shaped,
Gram-negative bacterium that is an opportunistic pathogen and
frequently causes life-threatening infections in burn, cancer, cystic
fibrosis, immuno-compromised, and intensive care patients (1-3). The
initial stage of Pseudomonas infection is the adherence of
the pathogen to the mucosal cells of a susceptible host, which is
mediated by a type IV pilus (2-5). These type IV pili are produced by a variety of bacterial pathogens, including Pseudomonas,
Neisseria, Moraxella, Dichelobacter, and Vibrio.
While type IV pili are critical virulence factors, they also play a
central role in twitching motility (6), DNA transformation, and
bacteriophage absorption (7). Type IV pili are long fibers that extend
from the bacterial surface and are composed of a single structural
protein, pilin. These pili are ~1,000-4,000 nm long, 5.2 nm in outer
diameter (4, 8) and can be lengthened or retracted by assembly or disassembly of pilin subunits at the base of the pilus. The retraction of the pilus powers twitching motility and gliding motility (9).
Pilin is encoded by the pilA gene of the pil
operon (10), and is initially synthesized as a precursor, pre-pilin,
which is cleaved, N-methylated, and assembled into a pilus.
Each pilin protein contains a functional receptor-binding site;
however, binding sites are only displayed at the tip of the pilus (11). This region is proposed to be the point of first contact between bacterial and host cells; consequently, pilus-mediated binding is
considered a tip-associated event (11). Up to five pilin monomers are
exposed at the tip of the pilus, resulting in multivalent receptor
binding as is common for lectin-carbohydrate interactions (12). The
multivalency of the pilus and its variability in length have confounded
the determination of accurate affinity constants for the pilus-cell
surface interaction and prevented a comparison of the binding
affinities of pili and synthetic receptor-binding domains.
The C-terminal receptor-binding domain of pilin has been studied in
detail for many different strains of P. aeruginosa.
Extensive structural analysis of free peptides that form the
C-terminal-binding domain has shown the presence of a type I -turn
followed by a type II -turn (13, 14). Interestingly, the
Neisseria gonorrhoeae strain MS-11 pilin
contains two type I -turns rather than a type I turn followed by a
type II turn that is seen in
PAK1 and PAO (13, 15, 16).
The major host cell-surface receptors for the P. aeruginosa
pilin C-terminal receptor-binding domains are the common cell surface
glycosphingolipids asialo-GM1 and asialo-GM2 (5, 17-20) which are
up-regulated in susceptible patients. The minimal portion of the cell
surface receptors asialo-GM1 and asialo-GM2
recognized by the receptor-binding domain consists of the disaccharide
GalNAc(1-4) Gal (18-20).
P. aeruginosa has both high innate resistance and a high
frequency of acquired anti-microbial resistance (21). Treatment of
P. aeruginosa infections is frequently problematic and
associated with high morbidity and mortality rates in susceptible
patient groups. Thus there is a significant interest in developing a
vaccine against Pseudomonas. Antibodies have been raised
against several proteins expressed by the bacteria including elastase,
exotoxin A, and lipoprotein I (22-24) as well as against various
polysaccharides (25). The C-terminal receptor-binding domain of pilin
has been a natural target for vaccine development due to its early role in the attachment and infection process. The feasibility of using type
IV pilus vaccines has been effectively demonstrated in both sheep and
cattle where protection against Dichelobacter nodosus and
Moraxella bovis, respectively, has been observed with
pili-based vaccines (26, 27). A free peptide of this domain from PAK has been successfully used to produce monoclonal and polyclonal antibodies that confer protection in an animal infection model (28).
Synthetic peptide analogues based on this domain have been used to
produce antibodies that show cross-reactivity between different
P. aeruginosa strains (29) and have been successfully used
to generate vaccines.
Herein, we describe the structure of a truncated, monomeric type IV
pilin from P. aeruginosa strain K122-4 using NMR
spectroscopy. The first 28 residues were truncated to prevent
oligomerization. We demonstrate that this truncated protein retains the
biological characteristics of the intact pilin monomer. This monomeric
pilin is able to compete for receptor binding sites with a heterologous strain of Pseudomonas resulting in a significant decrease in
mortality in an animal infection model. It follows, therefore, that the pilin monomer also retains the biological characteristics of the pilus
fiber except for the oligomerization properties of the N-terminal 28 residues. We have developed a model for the formation of the pilus
fiber based on electrostatic interactions between the globular portion
of the pilin protein and previous x-ray diffraction data on pilus
fibers (8). Currently, this model is the best fit to the x-ray fiber
diffraction data. The results presented here contribute significantly
to our understanding of the structure and function of type IV pili and
will aid in the development of novel therapeutic strategies for
managing and preventing Pseudomonas infections.
 |
EXPERIMENTAL PROCEDURES |
Protein Samples--
A DNA sequence encoding P. aeruginosa strain K122-4 pilin(29-150) was polymerase
chain reaction-amplified from the full-length K122-4 pilin
cDNA and cloned into the pRLD expression vector such that it had an
in-frame OmpA leader sequence fused to the truncated pilin (30) using
standard techniques. Unlabeled and 15N labeled K122-4
pilin(29-150) was prepared from Escherichia
coli DH5 cells, transformed with the pRLD plasmid carrying the
K122-4 pilin(29-150) gene, grown in LB or minimal media
containing 15NH4Cl. K122-4
pilin(29-150) was extracted from the periplasm by osmotic
shock and purified by cation exchange with a CM-cellulose column
(utilizing a linear gradient of 0-0.8 M NaCl) in 10 mM sodium acetate, pH 4.5. K122-4 pilin(29-150) was subsequently desalted on a Sephadex G75
column and lyophilized. The protein was deemed >95% pure by reverse
phase high performance liquid chromatography analysis. The molecular
weight of the sample was confirmed by electrospray mass spectroscopy
using a Fisons VG Quattro mass spectrometer. The identity of the
purified product was confirmed by N-terminal amino acid sequencing and
immunoblotting using rabbit polyclonal anti-K122-4 pilus antisera. NMR
analysis was performed on ~0.5 mM K122-4
pilin(29-150) dissolved in either 90%
H2O, 10% D2O or 99% D2O
containing 20 mM deuterated sodium acetate, 1 mM NaN3, and 1 mM
2,2-dimethyl-2-silapentane-5-sulfonic acid, pH 5.0.
Protein Characterization--
Sedimentation equilibrium analysis
of K122-4 pilin(29-150) was performed with a Beckman XL-I
analytical centrifuge with an AN50TI rotor at 20 °C. Data were
collected using interference optics. Three protein concentrations were
used: 0.75 mg ml 1, 2.03 mg ml 1 and 3.45 mg
ml 1, each in 20 mM sodium phosphate, pH 7.2, 100 mM sodium chloride. The molecular mass of the truncated
pilin was calculated from the protein concentration gradient at
sedimentation equilibrium using a partial specific volume of 0.7255 ml
g 1 as determined from the amino acid composition.
Sedimentation equilibrium data was evaluated using a least-squares
curve-fitting algorithm contained in the NonLin analysis program
(31).
NMR Spectroscopy--
NMR experiments were performed on Varian
Unity 600 and INOVA 800 MHz spectrometers at 30 °C. Spectra were
processed with NMRPipe (32) and analyzed using NMRView (33).
1H and 15N chemical shift assignments and may
be found with BMRB accession number 4918 (34).
An ensemble of 25 K122-4 pilin(29-150) structures was
generated from 1032 distance restraints, 30 hydrogen-bond and 181 dihedral angle restraints (PDB code 1HPW) by using the dynamic
simulated annealing protocols of Nilges et al. (35) in the
program X-PLOR version 3.8 (36). Interproton distance restraints were
derived from a three-dimensional 15N-NOESY HSQC spectrum in
H2O and a two-dimensional homonuclear NOESY spectra in
D2O both with a mix of 60 ms. NOEs were
classified as strong, medium, or weak depending on their intensity. A
list of NOE restraints used in structure calculations has been
submitted to the PDB (code 1HPW). H-bonds were determined by observing a two-dimensional TOCSY spectrum collected 6 days after dissolving the
protein sample in D2O buffer. 30 spin systems originating from backbone amide protons were observed and assigned as H-bonds after
initial examination of ensembles of structures generated without
incorporation of hydrogen bonds. Dihedral restraints were based on
3JHNH coupling constants measured
in a high resolution HNHA spectrum (37). angles were
determined by analysis of
dN /d N ratios but only incorporated into the regions of well defined secondary
structure (38). Stereospecific assignments and 1
restraints were obtained from the analysis of the
3J coupling
constants in DQF-COSY spectrum and the relative intensities of the NOEs
from the NH and the C to C protons in a
50-ms two-dimensional NOESY spectrum collected in D2O. All
structure calculations included the disulfide bonds, Cys31-Cys67 and
Cys103-Cys116 restrained to a distance of
2.02 ± 0.1 Å. No distance violations greater than 0.2 Å nor
dihedral violations greater than 2° were found. All nonglycine
residues in disallowed ( , ) regions are located in the disordered
termini of K122-4 pilin(29-150) (Table
I).
Receptor Binding Studies--
Pili from PAK were purified and
biotinylated as described previously (20, 39). A polystyrene microtiter
plate was coated with 50 µl of 40 µg ml 1
asialo-GM1 in methanol. The solvent was evaporated at room
temperature. Nonspecific binding sites were blocked by the addition of
200 µl per well of 5% (w/v) bovine serum albumin, in PBS buffer (150 mM NaCl, 10 mM sodium phosphate, pH 7.2). The
plate was incubated at 37 °C for 1.5 h and the wells were then
washed 3 times with 250 µl of 0.05% (w/v) bovine serum albumin in
PBS buffer. 50-µl aliquots of biotinylated PAK pili (0.88 µg
ml 1 in PBS buffer) containing various concentrations of
the K122-4 pilin(29-150) were added to each well. The
plate was incubated 2 h at 37 °C, washed (5 times with 250 µl
of PBS buffer), followed by the addition of 50 µl/well of
streptavidin-alkaline phosphatase conjugate at a 1:3000 dilution in
PBS. The plate was then incubated for 1 h at room temperature,
washed 5 times with 250 µl of PBS buffer, followed by the addition of
80 µl/well of the substrate solution (1 mg ml 1
p-nitrophenyl phosphate in 10% (v/v) diethanolamine, pH
9.8). Following a 10-min incubation at room temperature, microtiter plates were read at 405 nm.
Mice Infection Study--
This study was performed in accordance
with the Canadian Animal Care Guidelines and with the ethical approval
of the University of Alberta Health Science Animal Welfare Committee.
The A.BY/SnJ mice used in the study are a strain developed by Jackson
Laboratory (Bar Harbor, ME) that are highly susceptible to
Pseudomonas infection (40), with the LD50 for
PAK being ~3 × 105 colony forming units per mouse
when challenged intraperitoneally (27). A.BY/SnJ mice were obtained
from a breeding colony maintained behind barrier isolation. Mice were
transferred from the breeding colony at 3 weeks of age and maintained
in filtertop cages with a diet consisting of Purina PMI Certified
Rodent Diet 5002 until they were ~10 weeks of age and had a weight of
18-20 g. A double-blind study was then established where groups of 10 mice were administered, intraperitoneally, 100 µl of PBS, pH 7.2, containing either bovine serum albumin (400 µg) or K122-4
pilin(29-150) (100, 200, or 400 µg). Fifteen minutes
later, mice were challenged with ~5 times the LD50 of PAK
in 100 µl of LB administered intraperitoneally as previously
described (27, 28). Mice were monitored hourly from 16 to 48 h
post-challenge and euthanized when they displayed ruffled fur, evidence
of dehydration, and had become non-responsive to stimuli.
 |
RESULTS |
Truncation of K122-4 Pilin--
K122-4 pilin has significant
homology to the pilin sequences from other bacterial species (Fig.
1). The first 22 residues of pilin are
highly conserved. These residues are highly apolar and extend from the
rest of the protein. Consequently, they form an oligomerization domain
in pilin. Pilin from P. aeruginosa strain K122-4 was
engineered to exclude this oligomerization domain. The first 28 residues of the K122-4 pilin protein were therefore truncated to
produce a protein that will be referred to herein as K122-4
pilin(29-150).

View larger version (62K):
[in this window]
[in a new window]
|
Fig. 1.
Alignment of the sequences of pilin proteins
from P. aeruginosa strains K122-4, PAK, and PAO and
N. gonorrhoeae strain MS-11. In addition,
an S-pilin from N. gonorrhoeae strain FA1090 was included in
the alignment. The positions of highly conserved amino acids are
highlighted in black (three or more members identical), and
those of moderately conserved residues in gray. The
depiction of secondary structural elements are based on an average of
the start and stop points for each structural element over the first
four solved structures. The N-terminal -helix is illustrated as a
cylinder and the four -strands are illustrated as arrows.
Two additional -strands are found near the C terminus of the
sequences from N. gonorrhoeae. The oligomerization domains
(residues 1-22) are underlined in yellow, and
the C-terminal receptor-binding domain is underlined in
red. A blue arrow depicts where K122-4 pilin was truncated
for this study. The alignment was produced using the X-ALIGN software
(64).
|
|
Characterization of K122-4 Pilin(29-150)--
The
K122-4 pilin(29-150) was engineered to be exported to the
periplasm by means of an OmpA leader sequence (30). This protein was subsequently processed such that a soluble monomeric K122-4
pilin(29-150) with an additional 7 residues
(Ala-Leu-Glu-Gly-Thr-Glu-Phe numbered 22-28 in this article), were
fused to the N terminus of the K122-4 pilin(29-150) native
sequence. The purified protein was subsequently analyzed by mass
spectroscopy, analytical ultracentrifugation, and NMR. The mass of the
purified protein was observed to be 13,107 Da by electrospray mass
spectroscopy. Sedimentation equilibrium studies indicated a single
homogeneous species with a molecular mass of 13,077 Da. Both of these
values were in good agreement with the calculated molecular mass
of the monomer (13,105 Da). A rotational correlation time of 7.4 ns was
determined by NMR spectroscopic methods, which corresponds to a species
of ~14 kDa at 30 °C (41). Taken together, these data indicate that
K122-4 pilin(29-150) is monomeric up to the 0.5 mM concentrations used for NMR.
K122-4 Pilin(29-150) Retains the Functional
Characteristics of the Full-length Pilin Protein--
To determine if
the truncated form of the pilin protein from K122-4 was correctly
folded and functional, two separate experiments were performed: binding
of the truncated pilin to asialo-GM1, which requires a
functional receptor-binding domain (the C-terminal loop), and
protection of mice from P. aeruginosa infection by injection
with the truncated K122-4 pilin(29-150).
To determine if K122-4 pilin(29-150) retains
receptor-binding function, a competitive inhibition assay was
performed. The assay involved competitive binding between K122-4
pilin(29-150) and PAK pili (composed of the full-length
PAK pilin protein assembled into pili) with the pili receptor, the
naturally occurring membrane glycosphingolipid, asialo-GM1.
PAK pili were chosen for the assay as they bind to the same receptors
as K122-4 pili, are the best characterized and most readily purified
pilus type, and are the most extensively studied pili from P. aeruginosa. The truncated K122-4 pilin(29-150)
competitively inhibits PAK pili binding to immobilized
asialo-GM1 in a dose-dependent manner (Fig.
2A). This suggests that the
K122-4 pilin(29-150) monomer retains receptor-binding
capability, and that the receptor-binding domain is intact in the
truncated protein.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 2.
A, K122-4 pilin(29-150)
competitively inhibits the binding of biotinylated PAK pili to the
asialo-GM1 receptor. Inhibition is expressed as a
percentage of the decrease in the amount of biotinylated PAK pili bound
to the asialo-GM1 receptor as a function of the
concentration of K122-4 pilin(29-150). B,
influence, in a murine infection model, of pretreatment with K122-4
pilin(29-150) on the outcome of a challenge with PAK.
Pilin was administered intraperitoneally to A.BY/SnJ mice at 100 ( ),
200 ( ), and 400 µg ( ) per mouse. Bovine serum albumin ( ) was
used as a control at 400 µg/mouse. Mice were challenged IP with wild
type PAK at a dose of 1.6 × 106 colony forming
units/mouse, 15 min after receiving K122-4
pilin(29-150).
|
|
To determine if K122-4 pilin(29-150) could protect mice
against Pseudomonas infection, a double-blind study using
A.BY/SnJ mice was carried out. Intraperitoneal administration of
purified K122-4 pilin(29-150) in mice was found to delay
and decrease mortality by infection with PAK (Fig. 2B). The
protection afforded by K122-4 pilin(29-150) appears to be
dose-dependent, with both the 200 and 400 µg of dose of
K122-4 pilin(29-150) conferring substantial protection
against infection for over 35 h.
Description and Quality of the Structure of K122-4
Pilin(29-150)--
The structure of K122-4
pilin(29-150) was determined using NMR spectroscopy (Fig.
3). The C-terminal portion of the protein
folds into a four-stranded antiparallel -sheet structure composed of residues 78-87, 91-100, 110-119, and 126-133. This -sheet
structure folds around an -helix that is comprised of residues near
the N terminus (31-54). The -helix lies at approximately a 45°
angle from the axis of the -sheet (Fig. 3B). Most of the
hydrophobic residues point into the center of the molecule anchoring
the helix across the -sheet. The outer surface of the molecule is
composed primarily of polar residues. The hydrophobic interface between the helix and the four -strands, as well as the loops between them,
is comprised of residues Leu33, Leu39,
Leu43, Val47, Ile50, and
Phe51 of the -helix with residues Val81,
Ala87, Ile95, Ala97,
Leu113, Leu115, Leu117,
Trp127, and Leu138. These residues, for the
most part, appear to be conserved (Fig. 1). The secondary structural
elements constitute a well defined bundle with r.m.s. distributions
about the mean coordinate positions of 0.71 ± 0.18 Å for
backbone atoms, and 1.08 ± 0.17 Å for all heavy atoms. The loop
structures (residues 28-30, 55-77, 88-90, 101-109, 120-125, and
134-150) connecting the -helix and -strands are not as well
defined. Except for residues 76 and 77, these residues tend to display
random coil amide 1HN and 15N chemical shifts and high
r.m.s. deviations within the ensemble of calculated structures. The
first 7 residues of K122-4 pilin(29-150), that precede the
actual protein sequence starting at residue 29, are completely
disordered and thus will not be discussed further.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 3.
The tertiary structure of K122-4
pilin(29-150) was determined by NMR methods.
A, superimposition of the main chain atoms from the 10 lowest energy NMR-derived structures of K122-4
pilin(29-150) (PDB code 1HPW) superimposed using residues
31-54, 78-87, 91-100, 110-119, and 124-133. The -helix is
colored in blue, the -sheets are colored in
green, and the C-terminal receptor binding domain (which
includes part of the last -sheet) is colored in red. The
disordered N and C termini (residues 22-28 and 143-150) have been
omitted for clarity. B, the hydrophobic residues interacting
at the interface between the -helix and -sheets serve to sandwich
the -helix at approximately a 45° angle across the -sheets.
C, electrostatic surfaces generated using Delphi in
InsightII illustrating the differential charge distribution on the
surface of K122-4 pilin(29-150). The orientation of each
surface is shown below in Molscript format. Red
represents a negatively charged surface whereas blue
represents a positively charged surface. The labeling of charged
clusters is described in the text. The figure was prepared using
InsightII and Molscript.
|
|
The C-terminal receptor-binding domain of K122-4 pilin is composed of
residues Ala128-Gln143. As with peptide studies
of this region (14, 42), a -turn was found involving residues
Asp134, Asn135, Lys136, and
Tyr137. A second -turn involving residues
Pro139, Lys140, Thr141, and
Cys142 could not be unambiguously determined, due mainly to
the fact that resonances from residues Pro139,
Lys140, and Thr141 could not be assigned due to
NMR spectral overlap, resulting in poor definition of this region in
the K122-4 pilin(29-150) structure. We expect that this
portion of the receptor-binding domain does indeed form another
-turn by homology to the peptide studies and the crystal structures
of PAK and N. gonorrhoeae strain MS-11. The first 5 residues of the receptor-binding domain of K122-4
pilin(29-150) is composed of residues in the last strand
of the -sheet resulting in a highly defined structured region that
is not observed in isolated peptides from this C-terminal region
(42, 43).
The K122-4 pilin(29-150) protein has an unusual charge
distribution, as the charges are not distributed evenly on the surface
of the molecule, but tend to be clustered in 5 regions (Fig.
3C). Basic residues are clustered in three regions: (i)
Lys76, Lys80, Lys100,
Lys109, and Lys111 (on the side of the pilus
that faces the solvent), (ii) Arg30, Lys44,
Lys136, and Lys140 (near the C-terminal binding
loop), and (iii) Lys69 and Lys46 (on the
C-terminal side of the helix near the acidic cluster). The acidic
residues are clustered in two major regions: (iv) Asp49,
Asp54, Glu68, Asp70, and
Asp72 (along with Gln53, Asn60, and
Asn74) located C-terminal to the helix and (v)
Glu35, Asp103, and Asp134 (along
with Gln32, Asn131, Asn135, and
Gln143) located on the N-terminal side of the helix. Thus
distinct positive and negative regions exist on the molecule.
 |
DISCUSSION |
The C-terminal 122 residues of the type IV pilin from K122-4 adopt
a distinctive fold whereby the N-terminal -helix is surrounded by a
set of four curved antiparallel -strands. This fold closely resembles the x-ray crystal structures of pilin from N. gonorrhoeae strain MS-11 (PDB code 1AY2, Ref. 14) and a similarly
truncated version from PAK (PDB code 1DZ0, Ref. 15) (Fig.
4). 40% Pairwise amino acid identity
exists between pilin sequences of P. aeruginosa strain
K122-4 and PAK. Despite the large evolutionary differences between the
genera Neisseria and Pseudomonas, 39% pairwise
amino acid identity exists between the N. gonorrhoeae strain
MS-11 pilin and the P. aeruginosa strain K122-4 pilin (Fig.
1). All three structures have a similar fold with a similar curvature
of the -sheet that surrounds the C-terminal portion of the
-helix. The -helix of K122-4 pilin(29-150) lies at
approximately a 45° angle across the surface of the -sheet, whereas in the PAK and N. gonorrhoeae strain MS-11 pilin
crystal structures, the -helix is close to parallel to the
-sheet. This difference in structures is likely to be the result of
an additional disulfide bond found in K122-4 pilin as well as the
distribution of hydrophobic amino acids across the -strands, which
force the K122-4 pilin helix to lie at 45° (Fig. 3B). In
addition, the structures of the C-terminal receptor-binding domains of
all three proteins are similar. The major difference between the K122-4
pilin(29-150) structure and the N. gonorrhoeae
strain MS-11 pilin structure is that the MS-11 pilin structure contains
two -strands that are not seen in the K122-4
pilin(29-150) sequence or structure (Figs. 1 and 4).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
Molscript representations of the structures
of pilin monomers from P. aeruginosa strains K122-4
and PAK as well as N. gonorrhoeae strain MS-11 showing
the structural similarities. A, K122-4
pilin(29-150). B, PAK
pilin(29-144). C, full-length MS-11 pilin. The
N-terminal -helix is shown in blue, the -sheets are
shown in green, the C-terminal receptor binding domain is
shown in red, and the loop regions are shown in
gray. The part of the N-terminal -helix in the MS-11
pilin that has been truncated from K122-4 and PAK is shown in
orange. This figure was generated using Molscript.
|
|
Truncation of the Oligomerization Domain of the K122-4 Pilin
Protein Does Not Affect the Structure--
Analysis of the sequence
and structure of N. gonorrhoeae strain MS-11 pilin suggests
that the first 30 residues form an extended helix that does not
interact with the globular domain of the pilin. By homology, it follows
that the first 28 residues of K122-4 pilin could be removed without
affecting the fold of the remaining 122 residues. Truncation of part of
the N-terminal helix is not unprecedented, as there are naturally
occurring type IV pilins, termed S-pilins, which are missing several
residues at the N terminus (Fig. 1). N. gonorrhoeae S-pilin,
produced by N-terminal cleavage after residue 39 (Fig. 1), is a stable
soluble protein that is secreted into the extracellular environment
(44, 45). Similar soluble type IV pilins have been described in
Moraxella, where truncated pilins appear to be generated by
a site-specific recombinase (46, 47) rather than proteolysis. S-pilins
have been observed in N. gonorrhoeae infections in humans
(48), but their role in pathogenesis remains unclear. It has been
speculated that they could reduce antibody-mediated inactivation of
pili by capturing pilus-specific antibodies (49).
It has not been previously established if N-terminal truncated forms of
pilin retain their adhesion properties. Although there does not appear
to be a naturally occurring truncated version of a P. aeruginosa pilin, K122-4 pilin(29-150) is
nevertheless a good model for this class of pilins. Biophysical studies
demonstrate that K122-4 pilin(29-150) is a monomer.
Furthermore, K122-4 pilin(29-150) retains its receptor
binding capability as shown in a competitive inhibition assay with PAK
pili using the natural receptor asialo-GM1 (Fig.
2A). In addition, administration of K122-4
pilin(29-150) was able to confer some protection from
subsequent challenge with a heterologous strain of P. aeruginosa in a mouse infection model (Fig. 2B).
Presumably, K122-4 pilin(29-150) inhibits pili-mediated
binding of the challenge organism within the peritoneal cavity by a
competitive mechanism and inhibits the normal pathogenic mechanism of
the infecting organism such that mortality rates in the infection model
are reduced in a dose-dependent manner. There are several
potential explanations for this behavior. (i) If the adhesion pilus
plays a role in the dissemination of the pathogen from the initial
infection site, blockage of the receptor could limit dissemination of
the pathogen and thus reduce overall mortality. (ii) Alternatively,
protection may ensue due to modulation of the murine inflammatory
response by the truncated pilin. Several studies have suggested that
pilus-receptor interactions result in elevated expression of
interleukin-8. (iii) The initiation of host cell signaling by pili may
be due to the oligomerization of cell-surface receptors through
multivalent binding by the multiple receptor-binding domains displayed
at the tip of the pilus. Thus, the monomeric nature of K122-4
pilin(29-150) could inhibit the oligomerization of those
receptors, reducing the host inflammatory response and potentially
decreasing the severity of an infection. These data provide additional
evidence that monomeric K122-4 pilin(29-150) has retained
a biologically relevant conformation. Therefore, in general, in
addition to being possible antigenic decoys, S-pilins could reduce
bacterial adherence by competing with cell-associated pili for
receptors. Furthermore, S-pilins could also play a role in modulating
the host response to infection by modulating pilus-induced cell
signaling, as the protective effect observed with K122-4 pilin(29-150) could well be due to prevention of
pilus-induced cell signaling and the subsequent modulation of the host
inflammatory response.
Recently, there has been intense focus on the C-terminal
receptor-binding domain of the pilin protein. This region consists of
17 residues from 128 to 145 (Fig. 1), and has been shown to bind
asialo-GM1, asialo-GM2, and disaccharides such
as GalNAc(1-4) Gal (20). In addition, the C-terminal
receptor-binding domain is able to bind antibodies and hence is crucial
for successful infection by P. aeruginosa. NMR studies of
the C-terminal receptor-binding domain peptides of pilin from P. aeruginosa strains, PAK, PAO, and KB7 show evidence of a type I
and a type II -turn (42). N. gonorrhoeae strain MS11
pilin, however, was found to have two type I -turns (15). In K122-4
pilin(29-150), one type I -turn was found, however, the
other turn region was less well defined due to a lack of NOE
information because of spectral overlap. The fact that K122-4
pilin(29-150) can compete for receptor binding with intact
PAK, suggests that the second -turn is present.
Assembly of Pilin Monomers into a Pilus Fiber--
A number of
bacteria use type IV pili as adhesin molecules. However, the structural
organization, morphogenesis, and dynamics of type IV pili are not
completely understood (10). In vitro, the type IV pilus is
remarkably stable and its dissociation requires the use of detergents
(50). Nevertheless, in situ, the organism can readily
lengthen or retract the pilus by either adding to or removing pilin
monomers from the pilus filament in an energy dependent process (50,
51). Pilus retraction and twitching motility are significant virulence
factors in animal infection models. This lengthening and retraction is
believed to occur through highly regulated processes involving specific
chaperones and pilus morphogenesis machinery. Despite the complex
assembly apparatus, it has been observed that heterologous, and highly
divergent pilins, can be expressed and properly assembled into pili in
P. aeruginosa (52). Comparisons of type IV pilins show that
the hydrophobic N-terminal 22 residues form the only region with a
highly conserved amino acid sequence (Fig. 1). Furthermore, a glutamate
to lysine mutation at position 5 of PAK pilin prevents pilus formation
unless co-expressed with wild type pilin, in which case pili with
altered morphology are formed (53). All these observations point to the
fact that the N terminus is critical for pilus assembly.
Model for the Pilus Fiber--
The structure presented here
provides important additional clues for pilin assembly into a pilus
fiber. A model for the association of pilin monomers into a pilus fiber
was based on the structural studies presented here as well as previous
x-ray fiber diffraction data on pilin fibers (8). The key features of
this model are: (i) electrostatic surfaces of different monomers
interact in a complementary manner (Fig.
5A). (ii) The monomers are
offset such that they wind around in a helical manner with a
left-handed twist (Fig. 5B). (iii) Approximately 5 subunits
associate to form one turn of the helix. (iv) Hydrophobic N-terminal
helices associate to form 5-helix bundles with Glu5
interacting with the basic surface on the inside of the pilus globular
portion (Fig. 6E) (possibly
the conserved residue Arg30). (v) The outer diameter of the
pilus is ~52 Å with an inner diameter of the globular domains of 12 Å and a helical pitch of 41 Å (Fig. 6, A and
B).

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 5.
A proposed model for the formation of an
intact pilus. A, electrostatic complementarity allows
the globular domains of K122-4 pilin(29-150) to interact
slightly out of register. B, based on x-ray diffraction data
(8), five K122-4 pilin monomers can associate to form one turn of a
helical pilus structure. Using these data, a model was prepared by eye
using electrostatic complementarity. For each turn of the pilus,
complementary charged surfaces interact such that the positively
charged surface present on the face at the N terminus of the truncated
-helix interacts with the negatively charged surface present on the
face at the C terminus of the -helix. The three views are a side
view, a "top" view and a "bottom" view. The orientation of each
surface is represented by a Molscript diagram. The charged surfaces
were generated using Delphi in InsightII.
|
|

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 6.
Model of two turns of a pilus structure.
A, a view of the van der Waals surface of part of a pilus.
Each subunit (10 in total) is represented by a different color (one
turn has green hues and the other turn has blue
hues). The helical pitch of the pilus is ~41 Å, which is
approximately the length of the globular domain when measured with the
helix in a vertical position. B, a top view of a stick
diagram of the pilus showing the diameter of the pilus to be ~52 Å with an "inner diameter" between the globular surfaces of ~12 Å.
C, the Delphi electrostatic representation of two turns of
the pilus. Note the banding pattern of a positively charged surface on
the outside of the pilus. D, a Molscript representation of
C showing that the helices are present on the interior of
the pilus with the positive nature of the -sheets on the exterior of
the pilus. E, a proposed model of the oligomerization domain
(residues 1-28) of K122-4 pilin. The -helical structures were taken
from the N. gonorrhoeae MS-11 crystal structure. The helices
were oriented such that Phe 1 (gray stick) points toward the
center of the helices, Glu5 (red stick) points
outward from the helices, Tyr-(black stick) points to the
interface between the helices and Tyr27 (black
stick) points outward. Due to the extreme hydrophobic nature of
this part of the N-terminal helix, the 12 Å hole in the center of the
pilus measured by x-ray diffraction data would likely be mostly filled
with the hydrophobic side chains from this helix. The center of the
pilus will have a hydrophobic character and thus could not support the
movement of nucleic acids through the central channel of the
pilus.
|
|
The impetus for generating the pilus model was the observation of
electrostatic complementarity (Figs. 5 and 6, C and
D). Distinct areas of positive and negative charges exist on
the molecule allowing one to envisage a "lock and key" mechanism
for association of the globular portion of the monomer (Fig.
5A). In this model, the negatively charged area on one
"side" of the molecule interacts with the positively charged area
on the opposite "side." This causes an offset of the monomers and a
distinctive curvature to the pilus such that ~5 monomers associate to
form one twist of the left-handed helix. In solution, the coulombic
forces holding these monomers together would not be strong enough to
mediate oligomer formation due to solvation of the charged residues.
However, in the pilus these interactions would be complementary
possibly resulting in exclusion of water from the electrostatic
interface resulting in a stabilization of the pilus as a whole. Since
electrostatic interactions are easier to disrupt than hydrophobic
interactions, lengthening and shortening of the pilus would be a less
energetically costly event.
A previous model, based on the x-ray crystal structure of N. gonorrhoeae pilin (15), proposed a symmetric pilus with five subunits per turn and a helical pitch of ~41 Å. While our model agrees that ~5 subunits join to become one turn of the pilus helix, the two models differ in the sense that the model presented here is a
left-handed helix (dictated by the electrostatic surfaces) as opposed
to a right-handed helix proposed by Parge et al. (15, 53).
Furthermore, the left-handed helix allows for better packing such that
the inner and outer diameters more closely approximate those seen in
the x-ray fiber diffraction data.
The x-ray fiber diffraction data suggests there is a 12-Å "hole"
in the center of the pilus. Although we observe this with our truncated
K122-4 pilin pilus model (Fig. 6B), this "hole" is at
least partially filled by the hydrophobic side chains of the N-terminal
helices in both our model and that of Tainer and co-workers
(54). Indeed, it was suggested that this could be the case in
the x-ray fiber diffraction data of the pilus (8). Furthermore, due to
the fact that the center of the pilus is essentially hydrophobic,
passage of DNA or RNA through this center would be energetically
unfavorable. However, there may be enough space to allow for small
organic molecules to pass. The potential movement of organic molecules
through the pilus could allow for intercellular signaling mechanisms.
The fact that DNA or RNA might not be able to pass through the center
of the pilus does not necessarily imply that the involvement of type IV
pili in DNA transport is minimal. It has been well documented that type
IV pili play a role in both episomal gene transfer (55, 56) and DNA
transformation (57-59). However, while studies of bacterial
conjugation utilizing the F plasmid have clearly indicated the
importance of pili in this process, they have also established that DNA
transfer occurs only after a stable mating pair is formed and does not
appear to involve the F pilus directly (60-63). It might then be
suggested that type IV pilus involvement in DNA transport is minimal as
well. If the pilus does play an active role in DNA transport, the model
of the K122-4 pilus presented here suggests a different mechanism other
than movement through the center of the pilus. Our model reveals a
highly positively charged surface that coils around the filament (Fig.
6C) where the negatively charged DNA could potentially bind.
Upon pilus retraction, DNA could be transported into the cell.
Pilus-specific phage could also interact with the pilus, releasing
their nucleic acid which could then bind to the surface of the pilus
and thus be actively transported into the cell by retraction. These
structure-based hypotheses suggest that alteration of the surface
charge characteristics of the pilus would alter both DNA transformation
and phage sensitivity as well as disrupt the DNA transport and
conjugation systems. These are testable hypotheses and are currently
under investigation in our laboratory.
The importance of charged residues in forming proper pili is
exemplified by the fact that a Glu to Lys mutation at position 5 of the
pilin monomer (Fig. 6E) disrupts pilus formation (53). The
electrostatic repulsion of the lysine to obviously a basic site
(possibly Arg30) on the surface of one of the globular
domains in the pilus results in no pilus formation. In addition, if the
mutated pilin is co-expressed with wild-type pilin, it is easy for one
to envisage favorable and unfavorable interactions occurring resulting
in a pilus that will be kinked.
The structure of K122-4 pilin(29-150) presented here
is a paradigm for understanding how pilin monomers associate to form
the intact pilus structure. These structures are important in that they
allow us a better understanding of the immunological and receptor
binding properties of this protein. In addition, the results presented here will aid in the development of anti-adhesive therapeutic strategies and help to design vaccines for P. aeruginosa.
 |
ACKNOWLEDGEMENTS |
We thank L. Spyracopoulos, C. McInnes, P. Lavigne, and R. Read for valuable discussions. We acknowledge G. McQuaid and S. Gagné for maintenance and operation of NMR
spectrometers, respectively, and Prof. L. E. Kay for pulse
sequences. We gratefully acknowledge the technical assistance of M. Kaplan, D. Bautista, L. Glasier, W. Wong, C. Grant, and L. Hicks. 800 MHz NMR spectra were acquired at the Canadian National High Field NMR
Center (NANUC).
 |
FOOTNOTES |
*
This study was supported by the Canadian Bacterial Diseases
Network, the Protein Engineering Network Centers of Excellence, the
Canadian Institutes of Health Research, and Cytovax Biotechnologies Inc.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1HPW) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
**
To whom correspondence should be addressed: PENCE,713 Heritage
Medical Research Center, Edmonton, Alberta T6G 2S2, Canada. Fax:
780-492-1473; Tel.: 780-492-6540; E-mail:
brian.sykes@ualberta.ca.
Published, JBC Papers in Press, April 9, 2001, DOI 10.1074/jbc.M100659200
 |
ABBREVIATIONS |
The abbreviations used are:
PAK, Pseudomonas aeruginosa strain K;
DQF-COSY, double-quantum-filtered correlated spectroscopy;
HSQC, heteronuclear
single quantum coherence;
LB, Luria broth;
MS-11, Neisseria
gonorrhoeae strain MS-11;
NOESY, nuclear Overhauser enhancement
spectroscopy;
PAO, P. aeruginosa strain O;
PBS, phosphate-buffered saline;
r.m.s., root mean square;
TOCSY, total
correlation spectroscopy;
GalNAc(1-4) Gal, 2-acetamido-2-deoxy- -D- galactopyranosyl- -D-galactopyranoside;
asialo-GMI, gangliotetraosyl ceramide;
asialo-GM2, gangliotriaosyl
ceramide.
 |
REFERENCES |
| 1.
|
Bodey, G. P.,
Bolivar, R.,
Fainstein, V.,
and Jadeja, L.
(1983)
Rev. Infect. Dis.
5,
279-313
|
| 2.
|
Pier, G. B.
(1985)
J. Infect. Dis.
151,
575-580
|
| 3.
|
Irvin, R. T.
(1993)
in
Pseudomonas aeruginosa as an Opportunistic Pathogen
(Campa, M.
, Bendinelli, M.
, and Friedman, H., eds)
, pp. 19-42, Plenum Publishing Corp., New York
|
| 4.
|
Paranchych, W.,
Sastry, P. A.,
Volpel, K.,
Loh, B. A.,
and Speert, D. P.
(1986)
Clin. Invest. Med.
9,
113-118
|
| 5.
|
Lee, K. K.,
Doig, P.,
Irvin, R. T.,
Paranchych, W.,
and Hodges, R. S.
(1989)
Mol. Microbiol.
3,
1493-1499
|
| 6.
|
Bradley, D. E.
(1980)
Can. J. Microbiol.
26,
146-154
|
| 7.
|
Roncero, C.,
Darzins, A.,
and Casadaban, M. J.
(1990)
J. Bacteriol.
172,
1899-1904
|
| 8.
|
Folkhard, W. F.,
Marvin, D. A.,
Watts, T. H.,
and Paranchych, W.
(1981)
J. Mol. Biol.
149,
79-93
|
| 9.
|
Merz, A. J.,
So, M.,
and Sheetz, M. P.
(2000)
Nature
407,
98-102
|
| 10.
|
Mattick, J. S.,
Whitchurch, C. B.,
and Alm, R. A.
(1996)
Gene (Amst.)
179,
147-155
|
| 11.
|
Lee, K. K.,
Sheth, H. B.,
Wong, W. Y.,
Sherburne, R.,
Paranchych, W.,
Hodges, R. S.,
Lingwood, C. A.,
Krivan, H.,
and Irvin, R. T.
(1994)
Mol. Microbiol.
11,
705-713
|
| 12.
|
Rini, J. M.
(1995)
Annu. Rev. Biophys. Biomol. Struct.
24,
551-577
|
| 13.
|
Campbell, A. P.,
McInnes, C.,
Hodges, R. S.,
and Sykes, B. D.
(1995)
Biochemistry
34,
16255-16268
|
| 14.
|
Campbell, A. P.,
Sheth, H. B.,
Hodges, R. S.,
and Sykes, B. D.
(1996)
Int. J. Pept. Protein Res.
48,
539-552
|
| 15.
|
Parge, H. E.,
Forest, K. T.,
Hickey, M. J.,
Christensen, D. A.,
Getzoff, E. D.,
and Tainer, J. A.
(1995)
Nature
378,
32-38
|
| 16.
|
Hazes, B.,
Sastry, P. A.,
Hayakawa, K.,
Read, R. J.,
and Irvin, R. T.
(2000)
J. Mol. Biol.
299,
1005-1017
|
| 17.
|
Ramphal, R.,
Sadoff, J. C.,
Pyle, M.,
and Silipigni, J. D.
(1984)
Infect. Immun.
44,
38-40
|
| 18.
|
Ramphal, R.,
Carnoy, C.,
Fievre, S.,
Michalski, J. C.,
Houdret, N.,
Lamblin, G.,
Strecker, G.,
and Roussel, P.
(1991)
Infect. Immun.
59,
700-704
|
| 19.
|
Sheth, H. B.,
Lee, K. K.,
Paranchych, W.,
Hodges, R. S.,
and Irvin, R. T.
(1994)
Mol. Microbiol.
11,
715-723
|
| 20.
|
Yu, L.,
Lee, K. K.,
Hodges, R. S.,
Paranchych, W.,
and Irvin, R. T.
(1994)
Infect. Immun.
62,
5213-5219
|
| 21.
|
Alonso, A.,
Companario, E.,
and Martinez, J. L.
(1999)
Microbiology
145,
2857-2862
|
| 22.
|
Cryz, S. J.,
Fürer, E.,
and Germanier, R.
(1983)
Infect. Immun.
39,
1072-1079
|
| 23.
|
Lydick, E.,
McClean, A. A.,
Woodhour, A. F.,
and Callahan, L. T.
(1985)
J. Infect. Dis.
151,
375
|
| 24.
|
Finke, M.,
Muth, G.,
Reichhelm, T.,
Thoma, M.,
Duchene, M.,
Hungerer, K. D.,
Domdey, H.,
and von Specht, B. U.
(1991)
Infect. Immun.
59,
1251-1254
|
| 25.
|
Pier, G. B.,
and Thomas, D. M.
(1983)
J. Infect. Dis.
148,
206-213
|
| 26.
|
Pugh, G. W.,
Hughes, D. E.,
and Booth, G. D.
(1977)
Am. J. Vet. Res.
38,
1519-1522
|
| 27.
|
Farinha, M. A.,
Conway, B. D.,
Glasier, L. M. G.,
Ellert, N. W.,
Irvin, R. T.,
Sherburne, R.,
and Paranchych, W.
(1994)
Infect. Immun.
62,
4118-4123
|
| 28.
|
Sheth, H. B.,
Glasier, L. M.,
Ellert, N. W.,
Cachia, P.,
Kohn, W.,
Lee, K. K.,
Paranchych, W.,
Hodges, R. S.,
and Irvin, R. T.
(1995)
Biomedical Peptides Proteins Nucleic Acids
1,
141-148
|
| 29.
|
Cachia, P. J.,
Glasier, L. M.,
Hodgins, R. R.,
Wong, W. Y.,
Irvin, R. T.,
and Hodges, R. S.
(1998)
J. Peptide Res.
52,
289-299
|
| 30.
|
Tripet, B., Yu, L.,
Bautista, D. L.,
Wong, W. Y.,
Irvin, R. T.,
and Hodges, R. S.
(1996)
Protein Eng.
9,
1029-1042
|
| 31.
|
Johnson, M. L.,
Correia, J. J.,
Yphantis, D. A.,
and Halvorson, H. R.
(1981)
Biophys. J.
36,
575-588
|
| 32.
|
Delaglio, F.,
Grzesiek, S.,
Vuister, G. W.,
Zhu, G.,
Pfeifer, J.,
and Bax, A.
(1995)
J. Biomol. NMR
6,
277-293
|
| 33.
|
Johnson, B. A.,
and Blevins, R. A.
(1994)
J. Biomol. NMR
4,
603-614
|
| 34.
|
Keizer, D. W.,
Kalisiak, M.,
Crump, M. P.,
Suh, J. Y.,
Irvin, R.,
and Sykes, B. D.
(2001)
J. Biomol. NMR
19,
385-386
|
| 35.
|
Nilges, M.,
and O'Donoghu, S. I.
(1998)
Prog. Nuclear Mag. Res. Spectrosc.
32,
107-139
|
| 36.
|
Brünger, A. T.
(1993)
X-PLOR Version 3.1: A System for X-ray Crystallography and NMR
, Yale University Press, New Haven, CT
|
| 37.
|
Vuister, G. W.,
and Bax, A.
(1993)
J. Am. Chem. Soc.
115,
7772-7777
|
| 38.
|
Gagné, S. M.,
Tsuda, S.,
Li, M. X.,
Chandra, M.,
Smillie, L. B.,
and Sykes, B. D.
(1994)
Protein Sci.
3,
1961-1974
|
| 39.
|
Paranchych, W.,
Sastry, P. A.,
Frost, L. S.,
Carpenter, M.,
Armstrong, G. D.,
and Watts, T. H.
(1979)
Can. J. Microbiol.
25,
1175-1181
|
| 40.
|
Pennington, J. E.,
and Williams, R. M.
(1979)
J. Infect. Dis.
139,
396-400
|
| 41.
|
Suh, J. Y.,
Spyracopoulos, L.,
Keizer, D. W.,
Irvin, R. T.,
and Sykes, B. D.
(2001)
Biochemistry
40,
3985-3995
|
| 42.
|
Campbell, A. P.,
Wong, W. Y.,
Houston, M.,
Schweizer, F.,
Cachia, P. J.,
Irvin, R. T.,
Hindsgaul, O.,
Hodges, R. S.,
and Sykes, B. D.
(1997)
J. Mol. Biol.
267,
382-402
|
| 43.
|
Haas, R.,
Schwarz, H.,
and Meyer, T. F.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
9079-9083
|
| 44.
|
Marrs, C. F.,
Ruehl, W. H.,
Schoolnik, G. K.,
and Falkow, S.
(1988)
J. Bacteriol.
170,
3032-3039
|
| 45.
|
Long, C. D.,
Madraswala, R. N.,
and Seifert, H. S.
(1998)
Infect. Immun.
66,
1918-1927
|
| 46.
|
Swanson, J.,
Robbins, K.,
Barrera, O.,
and Koomey, J. M.
(1987)
J. Exp. Med.
165,
1016-1025
|
| 47.
|
Marrs, C. F.,
Rozsa, F. W.,
Hackel, M.,
Stevens, S. P.,
and Glasgow, A. C.
(1990)
J. Bacteriol.
172,
4370-4377
|
| 48.
|
Meyer, T. F.,
Gibbs, C. P.,
and Haas, R.
(1990)
Annu. Rev. Microbiol.
44,
451-477
|
| 49.
|
McInnes, C.,
Sönnichsen, F. D.,
Kay, C. M.,
Hodges, R. S.,
and Sykes, B. D.
(1993)
Biochemistry
32,
13432-13440
|
| 50.
|
Watts, T. H.,
Scraba, D. G.,
and Paranchych, W.
(1982)
J. Bacteriol.
151,
1508-1513
|
| 51.
|
Birnboim, H. C.,
and Doly, J.
(1979)
Nucleic Acids Res.
7,
1513-1523
|
| 52.
|
Beard, M. K. M.,
Mattick, J. S.,
Moore, L. J.,
Mott, M. R.,
Marrs, C. F.,
and Egerton, J. R.
(1990)
J. Bacteriol.
172,
2601-2607
|
| 53.
|
Pasloske, B. L.,
Scraba, D. G.,
and Paranchych, W.
(1989)
J. Bacteriol.
171,
2142-2147
|
| 54.
|
Forest, K, T.,
and Tainer, J. A.
(1997)
Gene (Amst.)
192,
165-169
|
| 55.
|
Kim, S.-R,
and Komano, T.
(1997)
J. Bacteriol.
179,
3594-3603
|
| 56.
|
Karaolis, D. K.,
Somara, S.,
Maneval, D. R.,
Johnson, J. A.,
and Kaper, J. B.
(1999)
Nature
399,
375-379
|
| 57.
|
Fussenegger, M.,
Rudel, T.,
Barten, R.,
Ryll, R.,
and Meyer, T. F.
(1997)
Gene (Amst.)
192,
125-134
|
| 58.
|
Wolfgang, M.,
Lauer, P.,
Park, H. S.,
Brossay, L.,
Hebert, J.,
and Koomey, M.
(1998)
Mol. Microbiol.
29,
321-330
|
| 59.
|
Wolfgang, M.,
van Putten, J. P.,
Hayes, S. F.,
and Koomey, M.
(1999)
Mol. Microbiol.
31,
1345-1357
|
| 60.
|
Durrenberger, M. B.,
Villiger, W.,
and Bachi, T.
(1991)
J. Struct. Biol.
107,
146-156
|
| 61.
|
Haase, J.,
Lurz, R.,
Grahn, A. M.,
Bamford, D. H.,
and Lanka, E.
(1995)
J. Bacteriol.
177,
4779-4791
|
| 62.
|
Klimke, W. A.,
and Frost, L. S.
(1998)
J. Bacteriol.
180,
4036-4043
|
| 63.
|
Silverman, P. M.
(1997)
Mol. Microbiol.
23,
423-429
|
| 64.
|
Wishart, D. S.,
Boyko, R. F.,
and Sykes, B. D.
(1994)
Comput. Appl. Biosci.
10,
687-688
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. L. Asikyan, J. V. Kus, and L. L. Burrows
Novel Proteins That Modulate Type IV Pilus Retraction Dynamics in Pseudomonas aeruginosa
J. Bacteriol.,
November 1, 2008;
190(21):
7022 - 7034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Shimoda, T. Muto, T. Horiuchi, N. Furuya, and T. Komano
Novel Class of Mutations of pilS Mutants, Encoding Plasmid R64 Type IV Prepilin: Interface of PilS-PilV Interactions
J. Bacteriol.,
February 15, 2008;
190(4):
1202 - 1208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Shen, S. Sayeed, P. Antalis, J. Gladitz, A. Ahmed, B. Dice, B. Janto, R. Dopico, R. Keefe, J. Hayes, et al.
Extensive Genomic Plasticity in Pseudomonas aeruginosa Revealed by Identification and Distribution Studies of Novel Genes among Clinical Isolates
Infect. Immun.,
September 1, 2006;
74(9):
5272 - 5283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Chen, R. Provvedi, and D. Dubnau
A Macromolecular Complex Formed by a Pilin-like Protein in Competent Bacillus subtilis
J. Biol. Chem.,
August 4, 2006;
281(31):
21720 - 21727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. de Bentzmann, M. Aurouze, G. Ball, and A. Filloux
FppA, a Novel Pseudomonas aeruginosa Prepilin Peptidase Involved in Assembly of Type IVb Pili
J. Bacteriol.,
July 1, 2006;
188(13):
4851 - 4860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Touhami, M. H. Jericho, J. M. Boyd, and T. J. Beveridge
Nanoscale Characterization and Determination of Adhesion Forces of Pseudomonas aeruginosa Pili by Using Atomic Force Microscopy
J. Bacteriol.,
January 15, 2006;
188(2):
370 - 377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ramboarina, P. J. Fernandes, S. Daniell, S. Islam, P. Simpson, G. Frankel, F. Booy, M. S. Donnenberg, and S. Matthews
Structure of the Bundle-forming Pilus from Enteropathogenic Escherichia coli
J. Biol. Chem.,
December 2, 2005;
280(48):
40252 - 40260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Hsieh, D. M. Tham, W. Feng, F. Huang, S. Embaie, K. Liu, D. Dean, R. Hertle, D. J. FitzGerald, and R. J. Mrsny
Intranasal Immunization Strategy To Impede Pilin-Mediated Binding of Pseudomonas aeruginosa to Airway Epithelial Cells
Infect. Immun.,
November 1, 2005;
73(11):
7705 - 7717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Lee, O. O. Kolade, K. Nomura, D. N. Arvidson, and S. Y. He
Use of Dominant-negative HrpA Mutants to Dissect Hrp Pilus Assembly and Type III Secretion in Pseudomonas syringae pv. tomato
J. Biol. Chem.,
June 3, 2005;
280(22):
21409 - 21417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. van Schaik, C. L. Giltner, G. F. Audette, D. W. Keizer, D. L. Bautista, C. M. Slupsky, B. D. Sykes, and R. T. Irvin
DNA Binding: a Novel Function of Pseudomonas aeruginosa Type IV Pili
J. Bacteriol.,
February 15, 2005;
187(4):
1455 - 1464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, R. Lux, A. E. Pelling, J. K. Gimzewski, and W. Shi
Analysis of type IV pilus and its associated motility in Myxococcus xanthus using an antibody reactive with native pilin and pili
Microbiology,
February 1, 2005;
151(2):
353 - 360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Z. Nevesinjac and T. L. Raivio
The Cpx Envelope Stress Response Affects Expression of the Type IV Bundle-Forming Pili of Enteropathogenic Escherichia coli
J. Bacteriol.,
January 15, 2005;
187(2):
672 - 686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Luke, A. J. Howlett, J. Shao, and A. A. Campagnari
Expression of Type IV Pili by Moraxella catarrhalis Is Essential for Natural Competence and Is Affected by Iron Limitation
Infect. Immun.,
November 1, 2004;
72(11):
6262 - 6270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-F. Xu, Y.-W. Tan, L. Lam, J. Hackett, M. Zhang, and Y.-K. Mok
NMR Structure of a Type IVb Pilin from Salmonella typhi and Its Assembly into Pilus
J. Biol. Chem.,
July 23, 2004;
279(30):
31599 - 31605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Kus, E. Tullis, D. G. Cvitkovitch, and L. L. Burrows
Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients
Microbiology,
May 1, 2004;
150(5):
1315 - 1326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Durand, A. Bernadac, G. Ball, A. Lazdunski, J. N. Sturgis, and A. Filloux
Type II Protein Secretion in Pseudomonas aeruginosa: the Pseudopilus Is a Multifibrillar and Adhesive Structure
J. Bacteriol.,
May 1, 2003;
185(9):
2749 - 2758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Comer, M. A. Marshall, V. J. Blanch, C. D. Deal, and P. Castric
Identification of the Pseudomonas aeruginosa 1244 Pilin Glycosylation Site
Infect. Immun.,
June 1, 2002;
70(6):
2837 - 2845.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|